Increased Risk of Diabetes and Diabetic Ketoacidosis Associated With COVID-19

Laura Montefusco¹, Ida Pastore¹, Maria Elena Lunati¹, Paolo Fiorina^{1

2

3}

Affiliations

¹ Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.
² International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche L. Sacco, Università di Milano, Milan, Italy.
³ Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Free article

Editorial

Laura Montefusco et al. Diabetes. 2023.

Free article

. 2023 May 1;72(5):560-561.

doi: 10.2337/db22-0908.

Laura Montefusco¹, Ida Pastore¹, Maria Elena Lunati¹, Paolo Fiorina^{1

2

3}

¹ Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.
² International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, Dipartimento di Scienze Biomediche e Cliniche L. Sacco, Università di Milano, Milan, Italy.
³ Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA.

No abstract available

Comment on

Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis.
Sharma A, Misra-Hebert AD, Mariam A, Milinovich A, Onuzuruike A, Koomson W, Kattan MW, Pantalone KM, Rotroff DM. Sharma A, et al. Diabetes. 2023 May 1;72(5):627-637. doi: 10.2337/db22-0264. Diabetes. 2023. PMID: 36107493